The research and development of bear bile powder in vitro by Shanghai Kaibao is expected to go further in the next year

Shanghai Kaibao (300039 SZ) insiders said that the key technology of cultivating bear bile powder in vitro has entered the critical period of pilot test, and it is expected to complete the kilogram level research and development within this year There will be a huge market space after the R & D of this product goes on the market "The key technology and preclinical research of bear bile powder in vitro" is to simulate the process of liver intestine circulation of bile acid synthesis in vitro, and the chicken bile powder is transformed into a product similar to bear bile powder in composition and efficacy It has been successful in the laboratory last year, and is now being transferred to the production workshop for "kilogram" transformation Bear gall has the effect of clearing away heat and detoxifying However, the way of extracting bear gall has been criticized by animal protection organizations and discussed by people in the legal field According to the insiders, the in vitro cultivation of bear bile powder being developed by Kaibao not only solves the problem of shortage of bear bile raw materials, but also opens a new way for the protection and sustainable utilization of endangered medicinal animal resources It is worth mentioning that the main raw material of the company's large variety of Tanreqing is bear bile powder According to the annual report, Shanghai Kaibao achieved a total operating revenue of 1.481 billion yuan in 2014, an increase of 11.93% over the same period of the previous year; the net profit attributable to shareholders of listed companies is 349 million yuan, an increase of 9.58% over the same period of the previous year Among them, the sales revenue of Tanreqing injection was 1.471 billion yuan, an increase of 11.90% over the same period of last year.